Study of the Utility of Post-Therapy Surveillance Scans in DLBCL


Study of the Utility of Post-Therapy Surveillance Scans in DLBCL
Slides from a presentation at ASCO 2013 and transcribed comments from a recent interview with Andrew M Evens, DO, MSc (10/26/13)
Thompson CA et al. Utility of post-therapy surveillance scans in DLBCL. Proc ASCO 2013;Abstract 8504.

Dr Evens is Professor of Medicine and Chief of the Division of Hematology/Oncology at Tufts University School of Medicine and Director of the Lymphoma Program and Leader of the Clinical Sciences Program at Tufts Cancer Center in Boston, Massachusetts.